How to foster new treatment development in ultra-rare tumours?: Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers

Ultra-rare sarcomas (URS) and ultra-rare cancers (URC) represent a unique challenge in oncology due to their rarity, heterogeneity, and the severe unmet clinical needs of affected patients. In 2024, the European Medicines Agency (EMA) and the European Organisation for Research and Treatment of Cance...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Stacchiotti, Silvia (VerfasserIn) , Pantziarka, Pan (VerfasserIn) , Leonard, Hugh (VerfasserIn) , Voltz, Caroline (VerfasserIn) , Abatedaga, Laura (VerfasserIn) , Bouche, Gauthier (VerfasserIn) , Bouygues, Christelle (VerfasserIn) , Bovee, Judith V. M. G. (VerfasserIn) , Van der Graaf, Winette T. A. (VerfasserIn) , Rojas, Teresa De (VerfasserIn) , D’Ambrosio, Lorenzo (VerfasserIn) , Donoghue, Martha (VerfasserIn) , Enzmann, Harald (VerfasserIn) , Feeney, Gerry (VerfasserIn) , Foggi, Paolo (VerfasserIn) , Frezza, Anna Maria (VerfasserIn) , Herold, Ralf (VerfasserIn) , Jones, Robin L. (VerfasserIn) , Kasper, Bernd (VerfasserIn) , Roes, Kit (VerfasserIn) , Marreaud, Sandrine (VerfasserIn) , Miceli, Rosalba (VerfasserIn) , Robinson, Denise (VerfasserIn) , Sommer, Josh (VerfasserIn) , Tap, William D. (VerfasserIn) , Tydings, Caitlin (VerfasserIn) , Trama, Annalisa (VerfasserIn) , Houdt, Winan Van (VerfasserIn) , van Oortmerssen, Gerard (VerfasserIn) , Wagner, Andrew J. (VerfasserIn) , Widemann, Brigitte (VerfasserIn) , Gelderblom, Hans (VerfasserIn) , Gronchi, Alessandro (VerfasserIn) , Napolitano, Andrea (VerfasserIn) , Dufresne, Armelle (VerfasserIn) , Fumagalli, Elena R. (VerfasserIn) , Baldi, Giacomo (VerfasserIn) , Marquina, Gloria (VerfasserIn) , Koseła-Paterczyk, Hanna (VerfasserIn) , Martin Javier, Javier Broto (VerfasserIn) , Junker, Niels (VerfasserIn) , Rutkowski, Piotr (VerfasserIn) , Oyen, Wim J. G. (VerfasserIn) , Lacombe, Denis (VerfasserIn) , Pignatti, Francesco (VerfasserIn) , Demolis, Pierre (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: November 2025
In: Cancer treatment reviews
Year: 2025, Jahrgang: 140, Pages: 1-10
ISSN:1532-1967
DOI:10.1016/j.ctrv.2025.103003
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ctrv.2025.103003
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0305737225001252
Volltext
Verfasserangaben:Silvia Stacchiotti, Pan Pantziarka, Hugh Leonard, Caroline Voltz, Laura Abatedaga, Gauthier Bouche, Christelle Bouygues, Judith V.M.G. Bovee, Winette T.A. Van der Graaf, Teresa De Rojas, Lorenzo D’Ambrosio, Martha Donoghue, Harald Enzmann, Gerry Feeney, Paolo Foggi, Anna Maria Frezza, Ralf Herold, Robin L. Jones, Bernd Kasper, Kit Roes, Sandrine Marreaud, Rosalba Miceli, Denise Robinson, Josh Sommer, William D. Tap, Caitlin Tydings, Annalisa Trama, Winan Van Houdt, Gerard van Oortmerssen, Andrew J. Wagner, Brigitte Widemann, Hans Gelderblom, Alessandro Gronchi, Andrea Napolitano, Armelle Dufresne, Elena R. Fumagalli, Giacomo Baldi, Gloria Marquina, Hanna Koseła-Paterczyk, Javier Broto Martin Javier, Niels Junker, Piotr Rutkowski, Wim J.G. Oyen, Denis Lacombe, Francesco Pignatti, Pierre Demolis

MARC

LEADER 00000naa a2200000 c 4500
001 1941397743
003 DE-627
005 20251117114720.0
007 cr uuu---uuuuu
008 251117s2025 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ctrv.2025.103003  |2 doi 
035 |a (DE-627)1941397743 
035 |a (DE-599)KXP1941397743 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Stacchiotti, Silvia  |e VerfasserIn  |0 (DE-588)1164087444  |0 (DE-627)1028474644  |0 (DE-576)508363071  |4 aut 
245 1 0 |a How to foster new treatment development in ultra-rare tumours?  |b Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers  |c Silvia Stacchiotti, Pan Pantziarka, Hugh Leonard, Caroline Voltz, Laura Abatedaga, Gauthier Bouche, Christelle Bouygues, Judith V.M.G. Bovee, Winette T.A. Van der Graaf, Teresa De Rojas, Lorenzo D’Ambrosio, Martha Donoghue, Harald Enzmann, Gerry Feeney, Paolo Foggi, Anna Maria Frezza, Ralf Herold, Robin L. Jones, Bernd Kasper, Kit Roes, Sandrine Marreaud, Rosalba Miceli, Denise Robinson, Josh Sommer, William D. Tap, Caitlin Tydings, Annalisa Trama, Winan Van Houdt, Gerard van Oortmerssen, Andrew J. Wagner, Brigitte Widemann, Hans Gelderblom, Alessandro Gronchi, Andrea Napolitano, Armelle Dufresne, Elena R. Fumagalli, Giacomo Baldi, Gloria Marquina, Hanna Koseła-Paterczyk, Javier Broto Martin Javier, Niels Junker, Piotr Rutkowski, Wim J.G. Oyen, Denis Lacombe, Francesco Pignatti, Pierre Demolis 
264 1 |c November 2025 
300 |b Diagramm 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 6. August 2025, Artikelversion: 10. August 2025 
500 |a Gesehen am 17.11.2025 
520 |a Ultra-rare sarcomas (URS) and ultra-rare cancers (URC) represent a unique challenge in oncology due to their rarity, heterogeneity, and the severe unmet clinical needs of affected patients. In 2024, the European Medicines Agency (EMA) and the European Organisation for Research and Treatment of Cancer (EORTC) convened two multi-stakeholder workshops, bringing together regulators, clinicians, researchers, and patient advocates. These workshops aimed to explore innovative strategies for treatment development and establish a framework for future collaboration. Key issues were discussed, including the scarcity of biological and clinical data, major barriers in conducting randomized trials, and limited pharmaceutical investment. A key outcome was the unanimous commitment of all stakeholders, including regulatory agencies such as EMA and the U.S. FDA, to work together towards pragmatic solutions. Participants recognized the necessity of flexible regulatory approaches, alternative trial designs, and meaningful endpoints tailored to ultra-rare conditions. The workshops also highlighted the importance of global collaboration, early regulatory engagement, and leveraging existing mechanisms like orphan drug designation and conditional approvals. The discussions emphasized that while scientific rigor must be upheld, regulatory frameworks must adapt to the specific challenges posed by URS. Stakeholders pledged to maintain open dialogue, share expertise, and develop innovative infrastructures to accelerate progress. This collaborative commitment marks a critical step forward in addressing the high unmet needs of URS. By fostering a unified effort among diverse stakeholders, the workshops established a model for advancing treatments in other URC, prioritizing patient outcomes while navigating the complexities of drug development for these challenging diseases. 
650 4 |a Drug development 
650 4 |a Methodology 
650 4 |a Regulatory agency 
650 4 |a Systemic treatment 
650 4 |a Trials 
650 4 |a Ultra-rare cancers 
650 4 |a Ultra-rare sarcoma 
700 1 |a Pantziarka, Pan  |e VerfasserIn  |4 aut 
700 1 |a Leonard, Hugh  |e VerfasserIn  |4 aut 
700 1 |a Voltz, Caroline  |e VerfasserIn  |4 aut 
700 1 |a Abatedaga, Laura  |e VerfasserIn  |4 aut 
700 1 |a Bouche, Gauthier  |e VerfasserIn  |4 aut 
700 1 |a Bouygues, Christelle  |e VerfasserIn  |4 aut 
700 1 |a Bovee, Judith V. M. G.  |e VerfasserIn  |4 aut 
700 1 |a Van der Graaf, Winette T. A.  |e VerfasserIn  |4 aut 
700 1 |a Rojas, Teresa De  |e VerfasserIn  |4 aut 
700 1 |a D’Ambrosio, Lorenzo  |e VerfasserIn  |4 aut 
700 1 |a Donoghue, Martha  |e VerfasserIn  |4 aut 
700 1 |a Enzmann, Harald  |e VerfasserIn  |4 aut 
700 1 |a Feeney, Gerry  |e VerfasserIn  |4 aut 
700 1 |a Foggi, Paolo  |e VerfasserIn  |4 aut 
700 1 |a Frezza, Anna Maria  |e VerfasserIn  |4 aut 
700 1 |a Herold, Ralf  |e VerfasserIn  |4 aut 
700 1 |a Jones, Robin L.  |e VerfasserIn  |4 aut 
700 1 |a Kasper, Bernd  |d 1974-  |e VerfasserIn  |0 (DE-588)12274764X  |0 (DE-627)082130736  |0 (DE-576)29340447X  |4 aut 
700 1 |a Roes, Kit  |e VerfasserIn  |4 aut 
700 1 |a Marreaud, Sandrine  |e VerfasserIn  |4 aut 
700 1 |a Miceli, Rosalba  |e VerfasserIn  |4 aut 
700 1 |a Robinson, Denise  |e VerfasserIn  |4 aut 
700 1 |a Sommer, Josh  |e VerfasserIn  |4 aut 
700 1 |a Tap, William D.  |e VerfasserIn  |4 aut 
700 1 |a Tydings, Caitlin  |e VerfasserIn  |4 aut 
700 1 |a Trama, Annalisa  |e VerfasserIn  |4 aut 
700 1 |a Houdt, Winan Van  |e VerfasserIn  |4 aut 
700 1 |a van Oortmerssen, Gerard  |e VerfasserIn  |4 aut 
700 1 |a Wagner, Andrew J.  |e VerfasserIn  |4 aut 
700 1 |a Widemann, Brigitte  |e VerfasserIn  |4 aut 
700 1 |a Gelderblom, Hans  |e VerfasserIn  |4 aut 
700 1 |a Gronchi, Alessandro  |e VerfasserIn  |4 aut 
700 1 |a Napolitano, Andrea  |e VerfasserIn  |4 aut 
700 1 |a Dufresne, Armelle  |e VerfasserIn  |4 aut 
700 1 |a Fumagalli, Elena R.  |e VerfasserIn  |4 aut 
700 1 |a Baldi, Giacomo  |e VerfasserIn  |4 aut 
700 1 |a Marquina, Gloria  |e VerfasserIn  |4 aut 
700 1 |a Koseła-Paterczyk, Hanna  |e VerfasserIn  |4 aut 
700 1 |a Martin Javier, Javier Broto  |e VerfasserIn  |4 aut 
700 1 |a Junker, Niels  |e VerfasserIn  |4 aut 
700 1 |a Rutkowski, Piotr  |e VerfasserIn  |4 aut 
700 1 |a Oyen, Wim J. G.  |e VerfasserIn  |4 aut 
700 1 |a Lacombe, Denis  |e VerfasserIn  |4 aut 
700 1 |a Pignatti, Francesco  |e VerfasserIn  |4 aut 
700 1 |a Demolis, Pierre  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cancer treatment reviews  |d Amsterdam [u.a.] : Elsevier, 1974  |g 140(2025) vom: Nov., Artikel-ID 103003, Seite 1-10  |h Online-Ressource  |w (DE-627)320417158  |w (DE-600)2002084-3  |w (DE-576)104194154  |x 1532-1967  |7 nnas  |a How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers 
773 1 8 |g volume:140  |g year:2025  |g month:11  |g elocationid:103003  |g pages:1-10  |g extent:10  |a How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers 
856 4 0 |u https://doi.org/10.1016/j.ctrv.2025.103003  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0305737225001252  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20251117 
993 |a Article 
994 |a 2025 
998 |g 12274764X  |a Kasper, Bernd  |m 12274764X:Kasper, Bernd  |d 60000  |d 61200  |e 60000PK12274764X  |e 61200PK12274764X  |k 0/60000/  |k 1/60000/61200/  |p 19 
999 |a KXP-PPN1941397743  |e 4807871676 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Silvia Stacchiotti, Pan Pantziarka, Hugh Leonard, Caroline Voltz, Laura Abatedaga, Gauthier Bouche, Christelle Bouygues, Judith V.M.G. Bovee, Winette T.A. Van der Graaf, Teresa De Rojas, Lorenzo D’Ambrosio, Martha Donoghue, Harald Enzmann, Gerry Feeney, Paolo Foggi, Anna Maria Frezza, Ralf Herold, Robin L. Jones, Bernd Kasper, Kit Roes, Sandrine Marreaud, Rosalba Miceli, Denise Robinson, Josh Sommer, William D. Tap, Caitlin Tydings, Annalisa Trama, Winan Van Houdt, Gerard van Oortmerssen, Andrew J. Wagner, Brigitte Widemann, Hans Gelderblom, Alessandro Gronchi, Andrea Napolitano, Armelle Dufresne, Elena R. Fumagalli, Giacomo Baldi, Gloria Marquina, Hanna Koseła-Paterczyk, Javier Broto Martin Javier, Niels Junker, Piotr Rutkowski, Wim J.G. Oyen, Denis Lacombe, Francesco Pignatti, Pierre Demolis"]},"person":[{"display":"Stacchiotti, Silvia","role":"aut","given":"Silvia","family":"Stacchiotti"},{"family":"Pantziarka","role":"aut","given":"Pan","display":"Pantziarka, Pan"},{"role":"aut","given":"Hugh","display":"Leonard, Hugh","family":"Leonard"},{"family":"Voltz","display":"Voltz, Caroline","given":"Caroline","role":"aut"},{"family":"Abatedaga","display":"Abatedaga, Laura","given":"Laura","role":"aut"},{"display":"Bouche, Gauthier","role":"aut","given":"Gauthier","family":"Bouche"},{"family":"Bouygues","role":"aut","given":"Christelle","display":"Bouygues, Christelle"},{"role":"aut","given":"Judith V. M. G.","display":"Bovee, Judith V. M. G.","family":"Bovee"},{"family":"Van der Graaf","display":"Van der Graaf, Winette T. A.","given":"Winette T. A.","role":"aut"},{"family":"Rojas","given":"Teresa De","role":"aut","display":"Rojas, Teresa De"},{"family":"D’Ambrosio","display":"D’Ambrosio, Lorenzo","given":"Lorenzo","role":"aut"},{"family":"Donoghue","role":"aut","given":"Martha","display":"Donoghue, Martha"},{"family":"Enzmann","role":"aut","given":"Harald","display":"Enzmann, Harald"},{"display":"Feeney, Gerry","given":"Gerry","role":"aut","family":"Feeney"},{"role":"aut","given":"Paolo","display":"Foggi, Paolo","family":"Foggi"},{"family":"Frezza","role":"aut","given":"Anna Maria","display":"Frezza, Anna Maria"},{"display":"Herold, Ralf","role":"aut","given":"Ralf","family":"Herold"},{"family":"Jones","display":"Jones, Robin L.","given":"Robin L.","role":"aut"},{"display":"Kasper, Bernd","role":"aut","given":"Bernd","family":"Kasper"},{"given":"Kit","role":"aut","display":"Roes, Kit","family":"Roes"},{"display":"Marreaud, Sandrine","role":"aut","given":"Sandrine","family":"Marreaud"},{"display":"Miceli, Rosalba","given":"Rosalba","role":"aut","family":"Miceli"},{"display":"Robinson, Denise","role":"aut","given":"Denise","family":"Robinson"},{"display":"Sommer, Josh","given":"Josh","role":"aut","family":"Sommer"},{"family":"Tap","display":"Tap, William D.","given":"William D.","role":"aut"},{"display":"Tydings, Caitlin","given":"Caitlin","role":"aut","family":"Tydings"},{"family":"Trama","role":"aut","given":"Annalisa","display":"Trama, Annalisa"},{"family":"Houdt","role":"aut","given":"Winan Van","display":"Houdt, Winan Van"},{"family":"van Oortmerssen","given":"Gerard","role":"aut","display":"van Oortmerssen, Gerard"},{"display":"Wagner, Andrew J.","role":"aut","given":"Andrew J.","family":"Wagner"},{"family":"Widemann","display":"Widemann, Brigitte","given":"Brigitte","role":"aut"},{"display":"Gelderblom, Hans","role":"aut","given":"Hans","family":"Gelderblom"},{"given":"Alessandro","role":"aut","display":"Gronchi, Alessandro","family":"Gronchi"},{"family":"Napolitano","display":"Napolitano, Andrea","role":"aut","given":"Andrea"},{"family":"Dufresne","given":"Armelle","role":"aut","display":"Dufresne, Armelle"},{"given":"Elena R.","role":"aut","display":"Fumagalli, Elena R.","family":"Fumagalli"},{"given":"Giacomo","role":"aut","display":"Baldi, Giacomo","family":"Baldi"},{"role":"aut","given":"Gloria","display":"Marquina, Gloria","family":"Marquina"},{"family":"Koseła-Paterczyk","role":"aut","given":"Hanna","display":"Koseła-Paterczyk, Hanna"},{"role":"aut","given":"Javier Broto","display":"Martin Javier, Javier Broto","family":"Martin Javier"},{"family":"Junker","display":"Junker, Niels","role":"aut","given":"Niels"},{"role":"aut","given":"Piotr","display":"Rutkowski, Piotr","family":"Rutkowski"},{"family":"Oyen","display":"Oyen, Wim J. G.","role":"aut","given":"Wim J. G."},{"family":"Lacombe","display":"Lacombe, Denis","role":"aut","given":"Denis"},{"family":"Pignatti","display":"Pignatti, Francesco","given":"Francesco","role":"aut"},{"family":"Demolis","display":"Demolis, Pierre","role":"aut","given":"Pierre"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"November 2025","dateIssuedKey":"2025"}],"recId":"1941397743","id":{"eki":["1941397743"],"doi":["10.1016/j.ctrv.2025.103003"]},"physDesc":[{"noteIll":"Diagramm","extent":"10 S."}],"relHost":[{"title":[{"title":"Cancer treatment reviews","title_sort":"Cancer treatment reviews"}],"language":["eng"],"part":{"pages":"1-10","extent":"10","year":"2025","text":"140(2025) vom: Nov., Artikel-ID 103003, Seite 1-10","volume":"140"},"pubHistory":["1.1974 -"],"origin":[{"publisherPlace":"Amsterdam [u.a.] ; Burlington, Mass.","dateIssuedKey":"1974","publisher":"Elsevier ; Harcourt","dateIssuedDisp":"1974-"}],"recId":"320417158","type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["320417158"],"issn":["1532-1967"],"zdb":["2002084-3"]},"disp":"How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancersCancer treatment reviews","note":["Gesehen am 22.01.2020"]}],"note":["Online verfügbar: 6. August 2025, Artikelversion: 10. August 2025","Gesehen am 17.11.2025"],"title":[{"title_sort":"How to foster new treatment development in ultra-rare tumours?","title":"How to foster new treatment development in ultra-rare tumours?","subtitle":"Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers"}],"language":["eng"]} 
SRT |a STACCHIOTTHOWTOFOSTE2025